Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2

Chi Chao Chan, Christian A. Koch, Muriel I. Kaiser-Kupfer, Dilys M. Parry, David H. Gutmann, Zhengping Zhuang, Alexander Vortmeyer

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Individuals affected with the neurofibromatosis 2 (NF2) cancer predisposition syndrome develop specific ocular lesions. To determine whether these lesions result from altered NF2 gene expression, microdissection and PCR were used to investigate 40 ocular lesions from seven eyes of four NF2 patients for LOH, with markers that flank the NF2 gene on chromosome 22q. NF2 protein (merlin) expression was also evaluated in these lesions, using immunohistochemistry. Retinal hamartoma was observed in all seven eyes, including one with combined pigment epithelial and retinal hamartoma (CPERH). Retinal tufts were present in four eyes (three patients), retinal dysplasia in two eyes (two patients), optic nerve neurofibroma in one eye, iris naevoid hyperplasia in two eyes (two patients) and pseudophakia in all eyes. Markers were informative in three patients (six eyes from three unrelated families). One patient was non-informative due to prolonged decalcification. All retinal and optic nerve, but not iris lesions, demonstrated consistent LOH for the NF2 gene. Merlin was not expressed in the retina, optic nerve, or iris lesions. These results suggest that inactivation of the NF2 gene is associated with the formation of a variety of retinal and optic nerve lesions in NF2 patients.

Original languageEnglish (US)
Pages (from-to)14-20
Number of pages7
JournalJournal of Pathology
Volume198
Issue number1
DOIs
StatePublished - Sep 1 2002
Externally publishedYes

Fingerprint

Neurofibromatosis 2 Genes
Neurofibromatosis 2
Loss of Heterozygosity
Optic Nerve
Iris
Neurofibromin 2
Hamartoma
Retinal Dysplasia
Pseudophakia
Neurofibroma
Microdissection
Retinal Pigments
Hyperplasia
Retina

Keywords

  • Hamartoma
  • Lisch nodule
  • Loss of heterozygosity
  • Merlin
  • Neurofibromatosis 2
  • Optic nerve glioma
  • Retina
  • Retinal dysplasia

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2. / Chan, Chi Chao; Koch, Christian A.; Kaiser-Kupfer, Muriel I.; Parry, Dilys M.; Gutmann, David H.; Zhuang, Zhengping; Vortmeyer, Alexander.

In: Journal of Pathology, Vol. 198, No. 1, 01.09.2002, p. 14-20.

Research output: Contribution to journalArticle

Chan, Chi Chao ; Koch, Christian A. ; Kaiser-Kupfer, Muriel I. ; Parry, Dilys M. ; Gutmann, David H. ; Zhuang, Zhengping ; Vortmeyer, Alexander. / Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2. In: Journal of Pathology. 2002 ; Vol. 198, No. 1. pp. 14-20.
@article{7d5d10cc2f944642babf97ae6326e004,
title = "Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2",
abstract = "Individuals affected with the neurofibromatosis 2 (NF2) cancer predisposition syndrome develop specific ocular lesions. To determine whether these lesions result from altered NF2 gene expression, microdissection and PCR were used to investigate 40 ocular lesions from seven eyes of four NF2 patients for LOH, with markers that flank the NF2 gene on chromosome 22q. NF2 protein (merlin) expression was also evaluated in these lesions, using immunohistochemistry. Retinal hamartoma was observed in all seven eyes, including one with combined pigment epithelial and retinal hamartoma (CPERH). Retinal tufts were present in four eyes (three patients), retinal dysplasia in two eyes (two patients), optic nerve neurofibroma in one eye, iris naevoid hyperplasia in two eyes (two patients) and pseudophakia in all eyes. Markers were informative in three patients (six eyes from three unrelated families). One patient was non-informative due to prolonged decalcification. All retinal and optic nerve, but not iris lesions, demonstrated consistent LOH for the NF2 gene. Merlin was not expressed in the retina, optic nerve, or iris lesions. These results suggest that inactivation of the NF2 gene is associated with the formation of a variety of retinal and optic nerve lesions in NF2 patients.",
keywords = "Hamartoma, Lisch nodule, Loss of heterozygosity, Merlin, Neurofibromatosis 2, Optic nerve glioma, Retina, Retinal dysplasia",
author = "Chan, {Chi Chao} and Koch, {Christian A.} and Kaiser-Kupfer, {Muriel I.} and Parry, {Dilys M.} and Gutmann, {David H.} and Zhengping Zhuang and Alexander Vortmeyer",
year = "2002",
month = "9",
day = "1",
doi = "10.1002/path.1174",
language = "English (US)",
volume = "198",
pages = "14--20",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2

AU - Chan, Chi Chao

AU - Koch, Christian A.

AU - Kaiser-Kupfer, Muriel I.

AU - Parry, Dilys M.

AU - Gutmann, David H.

AU - Zhuang, Zhengping

AU - Vortmeyer, Alexander

PY - 2002/9/1

Y1 - 2002/9/1

N2 - Individuals affected with the neurofibromatosis 2 (NF2) cancer predisposition syndrome develop specific ocular lesions. To determine whether these lesions result from altered NF2 gene expression, microdissection and PCR were used to investigate 40 ocular lesions from seven eyes of four NF2 patients for LOH, with markers that flank the NF2 gene on chromosome 22q. NF2 protein (merlin) expression was also evaluated in these lesions, using immunohistochemistry. Retinal hamartoma was observed in all seven eyes, including one with combined pigment epithelial and retinal hamartoma (CPERH). Retinal tufts were present in four eyes (three patients), retinal dysplasia in two eyes (two patients), optic nerve neurofibroma in one eye, iris naevoid hyperplasia in two eyes (two patients) and pseudophakia in all eyes. Markers were informative in three patients (six eyes from three unrelated families). One patient was non-informative due to prolonged decalcification. All retinal and optic nerve, but not iris lesions, demonstrated consistent LOH for the NF2 gene. Merlin was not expressed in the retina, optic nerve, or iris lesions. These results suggest that inactivation of the NF2 gene is associated with the formation of a variety of retinal and optic nerve lesions in NF2 patients.

AB - Individuals affected with the neurofibromatosis 2 (NF2) cancer predisposition syndrome develop specific ocular lesions. To determine whether these lesions result from altered NF2 gene expression, microdissection and PCR were used to investigate 40 ocular lesions from seven eyes of four NF2 patients for LOH, with markers that flank the NF2 gene on chromosome 22q. NF2 protein (merlin) expression was also evaluated in these lesions, using immunohistochemistry. Retinal hamartoma was observed in all seven eyes, including one with combined pigment epithelial and retinal hamartoma (CPERH). Retinal tufts were present in four eyes (three patients), retinal dysplasia in two eyes (two patients), optic nerve neurofibroma in one eye, iris naevoid hyperplasia in two eyes (two patients) and pseudophakia in all eyes. Markers were informative in three patients (six eyes from three unrelated families). One patient was non-informative due to prolonged decalcification. All retinal and optic nerve, but not iris lesions, demonstrated consistent LOH for the NF2 gene. Merlin was not expressed in the retina, optic nerve, or iris lesions. These results suggest that inactivation of the NF2 gene is associated with the formation of a variety of retinal and optic nerve lesions in NF2 patients.

KW - Hamartoma

KW - Lisch nodule

KW - Loss of heterozygosity

KW - Merlin

KW - Neurofibromatosis 2

KW - Optic nerve glioma

KW - Retina

KW - Retinal dysplasia

UR - http://www.scopus.com/inward/record.url?scp=0036724355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036724355&partnerID=8YFLogxK

U2 - 10.1002/path.1174

DO - 10.1002/path.1174

M3 - Article

C2 - 12210058

AN - SCOPUS:0036724355

VL - 198

SP - 14

EP - 20

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 1

ER -